103 related articles for article (PubMed ID: 1976577)
1. Intragastric acidity and serum gastrin after sufotidine.
Mela GS; Caputo E; Villa G; Savarino V; Zentilin P
Gut; 1990 Sep; 31(9):1087-8. PubMed ID: 1976577
[No Abstract] [Full Text] [Related]
2. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
3. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Smith JT; Gavey C; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
[TBL] [Abstract][Full Text] [Related]
4. Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
Smith JT; Pounder RE
Gut; 1990 Mar; 31(3):291-3. PubMed ID: 1969833
[TBL] [Abstract][Full Text] [Related]
5. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
Stables R; Humphray JM; Reeves JJ
Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
[TBL] [Abstract][Full Text] [Related]
7. Loss of acid suppression during dosing with H2-receptor antagonists.
Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gastric secretion following single morning or twice daily oral administration of sufotidine to volunteers.
Johnston DA; Wormsley KG
Br J Clin Pharmacol; 1989 Oct; 28(4):403-7. PubMed ID: 2574050
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
Suzuki T; Kagami T; Uotani T; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Miyajima H; Furuta T
Eur J Clin Pharmacol; 2018 Jan; 74(1):45-52. PubMed ID: 28986609
[TBL] [Abstract][Full Text] [Related]
10. [Effect of histamine H2-antagonists on serum gastrin levels in gastric lumen-perfused rats].
Yagita M
J UOEH; 1988 Jun; 10(2):189-201. PubMed ID: 2900546
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Famotidine in gastric acidity, plasma secretin and gastrin in duodenal ulcer patients. With reference to 24-hour intragastric pH monitoring].
Shiratori K; Watanabe S; Maruyama M; Itoh Y; Adachi H; Kurokawa K; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):855-63. PubMed ID: 6146733
[No Abstract] [Full Text] [Related]
12. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
13. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
Gladziwa U; Wagner S; Sieberth HG; Klotz U
Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
[TBL] [Abstract][Full Text] [Related]
15. [Intragastric acidity, serum gastrin and serum levels of the H2 receptor oxmetidine administered by continuous infusion].
Wichmann GC; Körber R; Fölsch UR
Arzneimittelforschung; 1985; 35(8):1307-10. PubMed ID: 2866776
[TBL] [Abstract][Full Text] [Related]
16. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.
Chiverton SG; Burget DW; Hunt RH
Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265
[TBL] [Abstract][Full Text] [Related]
17. H2-receptor antagonists: intragastric acidity after repeated doses. Introduction.
Halter F
Aliment Pharmacol Ther; 1990; 4 Suppl 1():1-6. PubMed ID: 1983343
[No Abstract] [Full Text] [Related]
18. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.
Fullarton GM; McLauchlan G; Macdonald A; Crean GP; McColl KE
Gut; 1989 Apr; 30(4):449-54. PubMed ID: 2565860
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
20. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
